You are here: Industry Insights > COVID-19

News List

Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution contractpharma
May 11, 2020
Designed to evaluate clinical trial protocol and charter to determine if novel COVID endpoint adjudication pathways should be added.
Catalent Provides Clinical Support for COVID-19 Study contractpharma
May 11, 2020
Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patients.
Cadila Pharma shuts formulations unit after spate of coronavirus cases at plant expresspharma
May 08, 2020
A senior government official said that five employees had tested positive for COVID-19 six days back, while 21 others tested positive this week.
Japan Approves Remdesivir For Use On Severe COVID-19 Patients forbes.com
May 08, 2020
Japan approved the antiviral drug Remdesivir of the Gilead Sciences for the treatment of severe COVID-19 patients.
Vitamin D levels appear to play role in COVID-19 mortality rates Northwestern University
May 08, 2020
Patients with severe deficiency are twice as likely to experience major complications.
Rapid COVID-19 Genome Sequencing Aids Outbreak Investigations americanpharmaceuticalreview
May 08, 2020
Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 Research Panel for the Ion Torrent Genexus System.
Biomerica Receives CE Mark for 10 Minute COVID-19 Exposure Test americanpharmaceuticalreview
May 08, 2020
Biomerica has received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes.
Enlivex Initiates Phase II Trial of Allocetra in COVID-19 contractpharma
May 08, 2020
Will assess Allocetra in combination with therapy in patients with lung dysfunction.
CluePoints Tech Benefits Clinical Studies Affected by COVID-19 contractpharma
May 08, 2020
Its COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies.
CDMO pledges increased production of hydroxychloroquine sulfate, potential COVID-19 treatment europeanpharmaceuticalreview
May 08, 2020
The CDMO AMRI has said it will boost its production of the malaria drug hydroxychloroquine sulfate, identified as a potential COVID-19 treatment, following an emergency use authorisation from the FDA.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page